An Observational Study of Treatment Patterns and Safety Outcomes for Metastatic or Locally Recurrent Breast Cancer (VIRGO)

NCT00726661 · clinicaltrials.gov ↗
COMPLETED
Status
1287
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Genentech, Inc.